Literature DB >> 33483376

Global incidence and mortality of neonatal sepsis: a systematic review and meta-analysis.

Carolin Fleischmann1,2, Felix Reichert3,4,5, Alessandro Cassini6, Rosa Horner3, Thomas Harder3, Robby Markwart3,7, Marc Tröndle3, Yoanna Savova3, Niranjan Kissoon8, Peter Schlattmann9, Konrad Reinhart10, Benedetta Allegranzi6, Tim Eckmanns3.   

Abstract

BACKGROUND: Neonates are at major risk of sepsis, but data on neonatal sepsis incidence are scarce. We aimed to assess the incidence and mortality of neonatal sepsis worldwide.
METHODS: We performed a systematic review and meta-analysis. 13 databases were searched for the period January 1979-May 2019, updating the search of a previous systematic review and extending it in order to increase data inputs from low-income and middle-income countries (LMICs). We included studies on the population-level neonatal sepsis incidence that used a clinical sepsis definition, such as the 2005 consensus definition, or relevant ICD codes. We performed a random-effects meta-analysis on neonatal sepsis incidence and mortality, stratified according to sepsis onset, birth weight, prematurity, study setting, WHO region and World Bank income level.
RESULTS: The search yielded 4737 publications, of which 26 were included. They accounted for 2 797 879 live births and 29 608 sepsis cases in 14 countries, most of which were middle-income countries. Random-effects estimator for neonatal sepsis incidence in the overall time frame was 2824 (95% CI 1892 to 4194) cases per 100 000 live births, of which an estimated 17.6% 9 (95% CI 10.3% to 28.6%) died. In the last decade (2009-2018), the incidence was 3930 (95% CI 1937 to 7812) per 100 000 live births based on four studies from LMICs. In the overall time frame, estimated incidence and mortality was higher in early-onset than late-onset neonatal sepsis cases. There was substantial between-study heterogeneity in all analyses. Studies were at moderate to high risk of bias.
CONCLUSION: Neonatal sepsis is common and often fatal. Its incidence remains unknown in most countries and existing studies show marked heterogeneity, indicating the need to increase the number of epidemiological studies, harmonise neonatal sepsis definitions and improve the quality of research in this field. This can help to design and implement targeted interventions, which are urgently needed to reduce the high incidence of neonatal sepsis worldwide. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Entities:  

Keywords:  epidemiology; mortality; neonatology

Year:  2021        PMID: 33483376     DOI: 10.1136/archdischild-2020-320217

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  25 in total

1.  Estimating baseline rates of adverse perinatal and neonatal outcomes using a facility-based surveillance approach: A prospective observational study from the WHO Global Vaccine Safety Multi-Country Collaboration on safety in pregnancy.

Authors:  Apoorva Sharan; Anke L Stuurman; Shubhashri Jahagirdar; Varalakshmi Elango; Margarita Riera-Montes; Neeraj Kumar Kashyap; Jorne Biccler; Ramesh Poluru; Narendra Kumar Arora; Mathews Mathai; Punam Mangtani; Hugo Devlieger; Steven Anderson; Barbee Whitaker; Hui-Lee Wong; Allisyn Moran; Christine Guillard Maure
Journal:  EClinicalMedicine       Date:  2022-06-17

Review 2.  Epidermal Immunity and Function: Origin in Neonatal Skin.

Authors:  Marty O Visscher; Andrew N Carr; Vivek Narendran
Journal:  Front Mol Biosci       Date:  2022-06-08

3.  Contemporary Trends in Global Mortality of Sepsis Among Young Infants Less Than 90 Days: A Systematic Review and Meta-Analysis.

Authors:  Ming Ying Gan; Wen Li Lee; Bei Jun Yap; Shu Ting Tammie Seethor; Rachel G Greenberg; Jen Heng Pek; Bobby Tan; Christoph Paul Vincent Hornik; Jan Hau Lee; Shu-Ling Chong
Journal:  Front Pediatr       Date:  2022-06-03       Impact factor: 3.569

Review 4.  Interleukin-1: an important target for perinatal neuroprotection?

Authors:  Sharmony B Kelly; Elys Green; Rod W Hunt; Claudia A Nold-Petry; Alistair J Gunn; Marcel F Nold; Robert Galinsky
Journal:  Neural Regen Res       Date:  2023-01       Impact factor: 6.058

Review 5.  [Sepsis incidence in Germany and worldwide : Current knowledge and limitations of research using health claims data].

Authors:  C Fleischmann-Struzek; D Schwarzkopf; K Reinhart
Journal:  Med Klin Intensivmed Notfmed       Date:  2021-01-28       Impact factor: 1.552

6.  Six-sigma and quality planning of TORCH tests in the Peruvian population: a single-center cross-sectional study.

Authors:  Jeel Moya-Salazar; Bianca M SantaMaria; Marcia M Moya-Salazar; Víctor Rojas-Zumaran; Karina Chicoma-Flores; Hans Contreras-Pulache
Journal:  BMC Res Notes       Date:  2022-01-11

7.  Interleukin-1 blockade attenuates white matter inflammation and oligodendrocyte loss after progressive systemic lipopolysaccharide exposure in near-term fetal sheep.

Authors:  Sharmony B Kelly; Vanesa Stojanovska; Valerie A Zahra; Alison Moxham; Suzanne L Miller; Timothy J M Moss; Stuart B Hooper; Marcel F Nold; Claudia A Nold-Petry; Justin M Dean; Laura Bennet; Graeme R Polglase; Alistair J Gunn; Robert Galinsky
Journal:  J Neuroinflammation       Date:  2021-08-31       Impact factor: 8.322

8.  Clinical signs of possible serious infection and associated mortality among young infants presenting at first-level health facilities.

Authors:  Yasir Bin Nisar; Antoinette Tshefu; Adrien Lokangaka Longombe; Fabian Esamai; Irene Marete; Adejumoke Idowu Ayede; Ebunoluwa A Adejuyigbe; Robinson D Wammanda; Shamim Ahmad Qazi; Rajiv Bahl
Journal:  PLoS One       Date:  2021-06-30       Impact factor: 3.240

Review 9.  Pediatric sepsis biomarkers for prognostic and predictive enrichment.

Authors:  Hector R Wong
Journal:  Pediatr Res       Date:  2021-06-14       Impact factor: 3.953

Review 10.  Look Who's Talking: Host and Pathogen Drivers of Staphylococcus epidermidis Virulence in Neonatal Sepsis.

Authors:  Isabella A Joubert; Michael Otto; Tobias Strunk; Andrew J Currie
Journal:  Int J Mol Sci       Date:  2022-01-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.